Global Closed System Drug Transfer Device Market

Closed System Drug Transfer Device Comprehensive Study by Type (Membrane-to-membrane Systems, Needleless Systems), Application (Hospitals & Clinics, Oncology Centers, Other End Users), Component Type (Closed Vial Access Devices, Closed Syringe Safety Devices, Closed Bag/Line Access Devices), Technology Type (Diaphragm-based Devices, Compartmentalized Devices, Air Cleaning/Filtration Devices) Players and Region - Global Market Outlook to 2030

Closed System Drug Transfer Device Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Closed System Drug Transfer Device Market Scope
Closed System Drug Transfer Device (CSTD) is a medication move gadget that precisely precludes the exchange of natural contaminants into a framework and the departure of dangerous medication or fume fixations outside the framework, which intended to forestall the break of unsafe medication fumes into the earth during drug reconstitution and administration.USA commanded the Closed System Drug Transfer Device (CSTD) and is the biggest creation base. Notwithstanding the USA, there are some other creation territories, for example, Europe. Moreover, the rising adoption of chemotherapy and the improvement of regulatory guidelines regarding hazardous drugs are increasing the market phenomenon.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledBecton, Dickinson, and Company (United States), ICU Medical, Inc. (United States), Equashield LLC. (United States), B. Braun Melsungen AG (Germany), Corvida Medical (United States), Baxter International, Inc. (United States), VICTUS (United States), Caragen Ltd. (Ireland) and Simplivia Healthcare (Israel)
CAGR%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Closed System Drug Transfer Device market throughout the predicted period.

Becton, Dickinson, and Company (United States), ICU Medical, Inc. (United States), Equashield LLC. (United States), B. Braun Melsungen AG (Germany), Corvida Medical (United States), Baxter International, Inc. (United States), VICTUS (United States), Caragen Ltd. (Ireland) and Simplivia Healthcare (Israel) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Yukon Medical (United States), JMS Co., Ltd. (United States) and CODAN Medizinische Geräte GmbH & Co KG (Germany).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Closed System Drug Transfer Device market by Type , by Application (Hospitals & Clinics, Oncology Centers and Other End Users) and Region with country level break-up.

On the basis of geography, the market of Closed System Drug Transfer Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In January 2022, ICU Medical Inc. acquired Smiths Medical from Smiths Group plc. The Smiths Medical business involve syringe and ambulatory infusion devices, vascular access, and vital care products. This acquisition created a scaled US-based global competitor that increases the stability of the medical supply chain and can grow as clinical care models evolve. This acquisition helped company to expand its presence in closed system drug transfer device market
In February 2023, Becton, Dickinson, and Company announced the outcomes of a peer-reviewed study which shows that BD technology used to significantly reduce hazardous drug surface contamination and provide real-time measures to pharmacies and health care facilities. It monitor and improve the safety of health care workers and patients. This clinical study helped Becton, Dickinson, and Company to strengthened its presence in closed system drug transfer device market
NIOSH defines a Closed System Drug-Transfer Device (CSTD) as “a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of the hazardous drug or vapor concentrations outside the system” [NIOSH 2004]. Currently, CSTDs generally follow one of two design concepts, using either a physical barrier or an air-cleaning technology to prevent the escape of hazardous drugs into the work environment. When appropriately designed and used, CSTDs offer enhanced protection against potentially hazardous exposures to healthcare workers during the compounding and administration of hazardous drugs.

Influencing Trend:
High Adoption of Phaseal, a Pioneer in the CSTD Market and Rising Adoption of Automation in CSTD

Market Growth Drivers:
Increasing Number of Oncology Drug Approvals and Rising Incidence of Cancer Across the World

Challenges:
The Lack of Regulatory Policies Regarding Health Workers’ Safety in Emerging Countries is Expected to Restrict the Market Growth during the Forecast Period. and Gaps With Existing CSTDs

Restraints:
The flare-up of the pandemic has likewise influenced the CSTD (shut framework drug move gadgets) market over the globe. At present, most of the assembling organizations and examination establishments and focuses are engaged with diagnosing the COVID and antibodies to treat the lethal infection. Hence, the move of clinical gadget and exploration focuses and diagnostics research centers towards the COVID19 pandemic has thwarted the market development.

Opportunities:
Use of CSTDs in Other Therapeutic Areas and Adoption of Cancer Treatment Centers across the World

Key Target Audience
Manufacturers, Suppliers, Wholesalers, Distributors, and Retailers, Governmental bodies and Others

Report Objectives / Segmentation Covered

By Type
  • Membrane-to-membrane Systems
  • Needleless Systems
By Application
  • Hospitals & Clinics
  • Oncology Centers
  • Other End Users
By Component Type
  • Closed Vial Access Devices
  • Closed Syringe Safety Devices
  • Closed Bag/Line Access Devices

By Technology Type
  • Diaphragm-based Devices
  • Compartmentalized Devices
  • Air Cleaning/Filtration Devices

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Oncology Drug Approvals
      • 3.2.2. Rising Incidence of Cancer Across the World
    • 3.3. Market Challenges
      • 3.3.1. The Lack of Regulatory Policies Regarding Health Workers’ Safety in Emerging Countries is Expected to Restrict the Market Growth during the Forecast Period.
      • 3.3.2. Gaps With Existing CSTDs
    • 3.4. Market Trends
      • 3.4.1. High Adoption of Phaseal, a Pioneer in the CSTD Market
      • 3.4.2. Rising Adoption of Automation in CSTD
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Closed System Drug Transfer Device, by Type, Application, Component Type, Technology Type and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Closed System Drug Transfer Device (Value)
      • 5.2.1. Global Closed System Drug Transfer Device by: Type (Value)
        • 5.2.1.1. Membrane-to-membrane Systems
        • 5.2.1.2. Needleless Systems
      • 5.2.2. Global Closed System Drug Transfer Device by: Application (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Oncology Centers
        • 5.2.2.3. Other End Users
      • 5.2.3. Global Closed System Drug Transfer Device by: Component Type (Value)
        • 5.2.3.1. Closed Vial Access Devices
        • 5.2.3.2. Closed Syringe Safety Devices
        • 5.2.3.3. Closed Bag/Line Access Devices
      • 5.2.4. Global Closed System Drug Transfer Device by: Technology Type (Value)
        • 5.2.4.1. Diaphragm-based Devices
        • 5.2.4.2. Compartmentalized Devices
        • 5.2.4.3. Air Cleaning/Filtration Devices
      • 5.2.5. Global Closed System Drug Transfer Device Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Closed System Drug Transfer Device (Volume)
      • 5.3.1. Global Closed System Drug Transfer Device by: Type (Volume)
        • 5.3.1.1. Membrane-to-membrane Systems
        • 5.3.1.2. Needleless Systems
      • 5.3.2. Global Closed System Drug Transfer Device by: Application (Volume)
        • 5.3.2.1. Hospitals & Clinics
        • 5.3.2.2. Oncology Centers
        • 5.3.2.3. Other End Users
      • 5.3.3. Global Closed System Drug Transfer Device by: Component Type (Volume)
        • 5.3.3.1. Closed Vial Access Devices
        • 5.3.3.2. Closed Syringe Safety Devices
        • 5.3.3.3. Closed Bag/Line Access Devices
      • 5.3.4. Global Closed System Drug Transfer Device by: Technology Type (Volume)
        • 5.3.4.1. Diaphragm-based Devices
        • 5.3.4.2. Compartmentalized Devices
        • 5.3.4.3. Air Cleaning/Filtration Devices
      • 5.3.5. Global Closed System Drug Transfer Device Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Closed System Drug Transfer Device (Price)
      • 5.4.1. Global Closed System Drug Transfer Device by: Type (Price)
  • 6. Closed System Drug Transfer Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson, and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ICU Medical, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Equashield LLC. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B. Braun Melsungen AG (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Corvida Medical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Baxter International, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. VICTUS (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Caragen Ltd. (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Simplivia Healthcare (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Closed System Drug Transfer Device Sale, by Type, Application, Component Type, Technology Type and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Closed System Drug Transfer Device (Value)
      • 7.2.1. Global Closed System Drug Transfer Device by: Type (Value)
        • 7.2.1.1. Membrane-to-membrane Systems
        • 7.2.1.2. Needleless Systems
      • 7.2.2. Global Closed System Drug Transfer Device by: Application (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Oncology Centers
        • 7.2.2.3. Other End Users
      • 7.2.3. Global Closed System Drug Transfer Device by: Component Type (Value)
        • 7.2.3.1. Closed Vial Access Devices
        • 7.2.3.2. Closed Syringe Safety Devices
        • 7.2.3.3. Closed Bag/Line Access Devices
      • 7.2.4. Global Closed System Drug Transfer Device by: Technology Type (Value)
        • 7.2.4.1. Diaphragm-based Devices
        • 7.2.4.2. Compartmentalized Devices
        • 7.2.4.3. Air Cleaning/Filtration Devices
      • 7.2.5. Global Closed System Drug Transfer Device Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Closed System Drug Transfer Device (Volume)
      • 7.3.1. Global Closed System Drug Transfer Device by: Type (Volume)
        • 7.3.1.1. Membrane-to-membrane Systems
        • 7.3.1.2. Needleless Systems
      • 7.3.2. Global Closed System Drug Transfer Device by: Application (Volume)
        • 7.3.2.1. Hospitals & Clinics
        • 7.3.2.2. Oncology Centers
        • 7.3.2.3. Other End Users
      • 7.3.3. Global Closed System Drug Transfer Device by: Component Type (Volume)
        • 7.3.3.1. Closed Vial Access Devices
        • 7.3.3.2. Closed Syringe Safety Devices
        • 7.3.3.3. Closed Bag/Line Access Devices
      • 7.3.4. Global Closed System Drug Transfer Device by: Technology Type (Volume)
        • 7.3.4.1. Diaphragm-based Devices
        • 7.3.4.2. Compartmentalized Devices
        • 7.3.4.3. Air Cleaning/Filtration Devices
      • 7.3.5. Global Closed System Drug Transfer Device Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Closed System Drug Transfer Device (Price)
      • 7.4.1. Global Closed System Drug Transfer Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Closed System Drug Transfer Device: by Type(USD Million)
  • Table 2. Closed System Drug Transfer Device Membrane-to-membrane Systems , by Region USD Million (2018-2023)
  • Table 3. Closed System Drug Transfer Device Needleless Systems , by Region USD Million (2018-2023)
  • Table 4. Closed System Drug Transfer Device: by Application(USD Million)
  • Table 5. Closed System Drug Transfer Device Hospitals & Clinics , by Region USD Million (2018-2023)
  • Table 6. Closed System Drug Transfer Device Oncology Centers , by Region USD Million (2018-2023)
  • Table 7. Closed System Drug Transfer Device Other End Users , by Region USD Million (2018-2023)
  • Table 8. Closed System Drug Transfer Device: by Component Type(USD Million)
  • Table 9. Closed System Drug Transfer Device Closed Vial Access Devices , by Region USD Million (2018-2023)
  • Table 10. Closed System Drug Transfer Device Closed Syringe Safety Devices , by Region USD Million (2018-2023)
  • Table 11. Closed System Drug Transfer Device Closed Bag/Line Access Devices , by Region USD Million (2018-2023)
  • Table 12. Closed System Drug Transfer Device: by Technology Type(USD Million)
  • Table 13. Closed System Drug Transfer Device Diaphragm-based Devices , by Region USD Million (2018-2023)
  • Table 14. Closed System Drug Transfer Device Compartmentalized Devices , by Region USD Million (2018-2023)
  • Table 15. Closed System Drug Transfer Device Air Cleaning/Filtration Devices , by Region USD Million (2018-2023)
  • Table 16. South America Closed System Drug Transfer Device, by Country USD Million (2018-2023)
  • Table 17. South America Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 18. South America Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 19. South America Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 20. South America Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 21. Brazil Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 22. Brazil Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 23. Brazil Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 24. Brazil Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 25. Argentina Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 26. Argentina Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 27. Argentina Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 28. Argentina Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 29. Rest of South America Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 30. Rest of South America Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 31. Rest of South America Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 32. Rest of South America Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 33. Asia Pacific Closed System Drug Transfer Device, by Country USD Million (2018-2023)
  • Table 34. Asia Pacific Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 35. Asia Pacific Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 36. Asia Pacific Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 37. Asia Pacific Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 38. China Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 39. China Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 40. China Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 41. China Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 42. Japan Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 43. Japan Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 44. Japan Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 45. Japan Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 46. India Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 47. India Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 48. India Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 49. India Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 50. South Korea Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 51. South Korea Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 52. South Korea Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 53. South Korea Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 54. Taiwan Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 55. Taiwan Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 56. Taiwan Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 57. Taiwan Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 58. Australia Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 59. Australia Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 60. Australia Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 61. Australia Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 66. Europe Closed System Drug Transfer Device, by Country USD Million (2018-2023)
  • Table 67. Europe Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 68. Europe Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 69. Europe Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 70. Europe Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 71. Germany Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 72. Germany Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 73. Germany Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 74. Germany Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 75. France Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 76. France Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 77. France Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 78. France Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 79. Italy Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 80. Italy Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 81. Italy Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 82. Italy Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 83. United Kingdom Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 84. United Kingdom Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 85. United Kingdom Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 86. United Kingdom Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 87. Netherlands Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 88. Netherlands Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 89. Netherlands Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 90. Netherlands Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 91. Rest of Europe Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 92. Rest of Europe Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 93. Rest of Europe Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 94. Rest of Europe Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 95. MEA Closed System Drug Transfer Device, by Country USD Million (2018-2023)
  • Table 96. MEA Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 97. MEA Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 98. MEA Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 99. MEA Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 100. Middle East Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 101. Middle East Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 102. Middle East Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 103. Middle East Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 104. Africa Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 105. Africa Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 106. Africa Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 107. Africa Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 108. North America Closed System Drug Transfer Device, by Country USD Million (2018-2023)
  • Table 109. North America Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 110. North America Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 111. North America Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 112. North America Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 113. United States Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 114. United States Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 115. United States Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 116. United States Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 117. Canada Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 118. Canada Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 119. Canada Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 120. Canada Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 121. Mexico Closed System Drug Transfer Device, by Type USD Million (2018-2023)
  • Table 122. Mexico Closed System Drug Transfer Device, by Application USD Million (2018-2023)
  • Table 123. Mexico Closed System Drug Transfer Device, by Component Type USD Million (2018-2023)
  • Table 124. Mexico Closed System Drug Transfer Device, by Technology Type USD Million (2018-2023)
  • Table 125. Closed System Drug Transfer Device Sales: by Type(UNIT)
  • Table 126. Closed System Drug Transfer Device Sales Membrane-to-membrane Systems , by Region UNIT (2018-2023)
  • Table 127. Closed System Drug Transfer Device Sales Needleless Systems , by Region UNIT (2018-2023)
  • Table 128. Closed System Drug Transfer Device Sales: by Application(UNIT)
  • Table 129. Closed System Drug Transfer Device Sales Hospitals & Clinics , by Region UNIT (2018-2023)
  • Table 130. Closed System Drug Transfer Device Sales Oncology Centers , by Region UNIT (2018-2023)
  • Table 131. Closed System Drug Transfer Device Sales Other End Users , by Region UNIT (2018-2023)
  • Table 132. Closed System Drug Transfer Device Sales: by Component Type(UNIT)
  • Table 133. Closed System Drug Transfer Device Sales Closed Vial Access Devices , by Region UNIT (2018-2023)
  • Table 134. Closed System Drug Transfer Device Sales Closed Syringe Safety Devices , by Region UNIT (2018-2023)
  • Table 135. Closed System Drug Transfer Device Sales Closed Bag/Line Access Devices , by Region UNIT (2018-2023)
  • Table 136. Closed System Drug Transfer Device Sales: by Technology Type(UNIT)
  • Table 137. Closed System Drug Transfer Device Sales Diaphragm-based Devices , by Region UNIT (2018-2023)
  • Table 138. Closed System Drug Transfer Device Sales Compartmentalized Devices , by Region UNIT (2018-2023)
  • Table 139. Closed System Drug Transfer Device Sales Air Cleaning/Filtration Devices , by Region UNIT (2018-2023)
  • Table 140. South America Closed System Drug Transfer Device Sales, by Country UNIT (2018-2023)
  • Table 141. South America Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 142. South America Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 143. South America Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 144. South America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 145. Brazil Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 146. Brazil Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 147. Brazil Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 148. Brazil Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 149. Argentina Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 150. Argentina Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 151. Argentina Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 152. Argentina Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 153. Rest of South America Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 154. Rest of South America Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 155. Rest of South America Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 156. Rest of South America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 157. Asia Pacific Closed System Drug Transfer Device Sales, by Country UNIT (2018-2023)
  • Table 158. Asia Pacific Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 159. Asia Pacific Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 160. Asia Pacific Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 161. Asia Pacific Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 162. China Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 163. China Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 164. China Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 165. China Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 166. Japan Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 167. Japan Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 168. Japan Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 169. Japan Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 170. India Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 171. India Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 172. India Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 173. India Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 174. South Korea Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 175. South Korea Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 176. South Korea Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 177. South Korea Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 178. Taiwan Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 179. Taiwan Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 180. Taiwan Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 181. Taiwan Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 182. Australia Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 183. Australia Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 184. Australia Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 185. Australia Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 186. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 187. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 188. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 189. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 190. Europe Closed System Drug Transfer Device Sales, by Country UNIT (2018-2023)
  • Table 191. Europe Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 192. Europe Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 193. Europe Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 194. Europe Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 195. Germany Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 196. Germany Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 197. Germany Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 198. Germany Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 199. France Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 200. France Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 201. France Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 202. France Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 203. Italy Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 204. Italy Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 205. Italy Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 206. Italy Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 207. United Kingdom Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 208. United Kingdom Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 209. United Kingdom Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 210. United Kingdom Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 211. Netherlands Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 212. Netherlands Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 213. Netherlands Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 214. Netherlands Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 215. Rest of Europe Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 216. Rest of Europe Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 217. Rest of Europe Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 218. Rest of Europe Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 219. MEA Closed System Drug Transfer Device Sales, by Country UNIT (2018-2023)
  • Table 220. MEA Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 221. MEA Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 222. MEA Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 223. MEA Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 224. Middle East Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 225. Middle East Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 226. Middle East Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 227. Middle East Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 228. Africa Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 229. Africa Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 230. Africa Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 231. Africa Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 232. North America Closed System Drug Transfer Device Sales, by Country UNIT (2018-2023)
  • Table 233. North America Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 234. North America Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 235. North America Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 236. North America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 237. United States Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 238. United States Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 239. United States Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 240. United States Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 241. Canada Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 242. Canada Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 243. Canada Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 244. Canada Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 245. Mexico Closed System Drug Transfer Device Sales, by Type UNIT (2018-2023)
  • Table 246. Mexico Closed System Drug Transfer Device Sales, by Application UNIT (2018-2023)
  • Table 247. Mexico Closed System Drug Transfer Device Sales, by Component Type UNIT (2018-2023)
  • Table 248. Mexico Closed System Drug Transfer Device Sales, by Technology Type UNIT (2018-2023)
  • Table 249. Closed System Drug Transfer Device: by Type(USD/Units)
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Closed System Drug Transfer Device: by Type(USD Million)
  • Table 260. Closed System Drug Transfer Device Membrane-to-membrane Systems , by Region USD Million (2025-2030)
  • Table 261. Closed System Drug Transfer Device Needleless Systems , by Region USD Million (2025-2030)
  • Table 262. Closed System Drug Transfer Device: by Application(USD Million)
  • Table 263. Closed System Drug Transfer Device Hospitals & Clinics , by Region USD Million (2025-2030)
  • Table 264. Closed System Drug Transfer Device Oncology Centers , by Region USD Million (2025-2030)
  • Table 265. Closed System Drug Transfer Device Other End Users , by Region USD Million (2025-2030)
  • Table 266. Closed System Drug Transfer Device: by Component Type(USD Million)
  • Table 267. Closed System Drug Transfer Device Closed Vial Access Devices , by Region USD Million (2025-2030)
  • Table 268. Closed System Drug Transfer Device Closed Syringe Safety Devices , by Region USD Million (2025-2030)
  • Table 269. Closed System Drug Transfer Device Closed Bag/Line Access Devices , by Region USD Million (2025-2030)
  • Table 270. Closed System Drug Transfer Device: by Technology Type(USD Million)
  • Table 271. Closed System Drug Transfer Device Diaphragm-based Devices , by Region USD Million (2025-2030)
  • Table 272. Closed System Drug Transfer Device Compartmentalized Devices , by Region USD Million (2025-2030)
  • Table 273. Closed System Drug Transfer Device Air Cleaning/Filtration Devices , by Region USD Million (2025-2030)
  • Table 274. South America Closed System Drug Transfer Device, by Country USD Million (2025-2030)
  • Table 275. South America Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 276. South America Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 277. South America Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 278. South America Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 279. Brazil Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 280. Brazil Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 281. Brazil Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 282. Brazil Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 283. Argentina Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 284. Argentina Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 285. Argentina Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 286. Argentina Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 287. Rest of South America Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 288. Rest of South America Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 289. Rest of South America Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 290. Rest of South America Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 291. Asia Pacific Closed System Drug Transfer Device, by Country USD Million (2025-2030)
  • Table 292. Asia Pacific Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 293. Asia Pacific Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 294. Asia Pacific Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 295. Asia Pacific Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 296. China Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 297. China Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 298. China Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 299. China Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 300. Japan Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 301. Japan Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 302. Japan Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 303. Japan Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 304. India Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 305. India Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 306. India Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 307. India Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 308. South Korea Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 309. South Korea Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 310. South Korea Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 311. South Korea Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 312. Taiwan Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 313. Taiwan Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 314. Taiwan Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 315. Taiwan Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 316. Australia Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 317. Australia Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 318. Australia Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 319. Australia Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 320. Rest of Asia-Pacific Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 321. Rest of Asia-Pacific Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 322. Rest of Asia-Pacific Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 323. Rest of Asia-Pacific Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 324. Europe Closed System Drug Transfer Device, by Country USD Million (2025-2030)
  • Table 325. Europe Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 326. Europe Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 327. Europe Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 328. Europe Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 329. Germany Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 330. Germany Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 331. Germany Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 332. Germany Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 333. France Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 334. France Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 335. France Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 336. France Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 337. Italy Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 338. Italy Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 339. Italy Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 340. Italy Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 341. United Kingdom Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 342. United Kingdom Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 343. United Kingdom Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 344. United Kingdom Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 345. Netherlands Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 346. Netherlands Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 347. Netherlands Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 348. Netherlands Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 349. Rest of Europe Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 350. Rest of Europe Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 351. Rest of Europe Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 352. Rest of Europe Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 353. MEA Closed System Drug Transfer Device, by Country USD Million (2025-2030)
  • Table 354. MEA Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 355. MEA Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 356. MEA Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 357. MEA Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 358. Middle East Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 359. Middle East Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 360. Middle East Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 361. Middle East Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 362. Africa Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 363. Africa Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 364. Africa Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 365. Africa Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 366. North America Closed System Drug Transfer Device, by Country USD Million (2025-2030)
  • Table 367. North America Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 368. North America Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 369. North America Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 370. North America Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 371. United States Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 372. United States Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 373. United States Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 374. United States Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 375. Canada Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 376. Canada Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 377. Canada Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 378. Canada Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 379. Mexico Closed System Drug Transfer Device, by Type USD Million (2025-2030)
  • Table 380. Mexico Closed System Drug Transfer Device, by Application USD Million (2025-2030)
  • Table 381. Mexico Closed System Drug Transfer Device, by Component Type USD Million (2025-2030)
  • Table 382. Mexico Closed System Drug Transfer Device, by Technology Type USD Million (2025-2030)
  • Table 383. Closed System Drug Transfer Device Sales: by Type(UNIT)
  • Table 384. Closed System Drug Transfer Device Sales Membrane-to-membrane Systems , by Region UNIT (2025-2030)
  • Table 385. Closed System Drug Transfer Device Sales Needleless Systems , by Region UNIT (2025-2030)
  • Table 386. Closed System Drug Transfer Device Sales: by Application(UNIT)
  • Table 387. Closed System Drug Transfer Device Sales Hospitals & Clinics , by Region UNIT (2025-2030)
  • Table 388. Closed System Drug Transfer Device Sales Oncology Centers , by Region UNIT (2025-2030)
  • Table 389. Closed System Drug Transfer Device Sales Other End Users , by Region UNIT (2025-2030)
  • Table 390. Closed System Drug Transfer Device Sales: by Component Type(UNIT)
  • Table 391. Closed System Drug Transfer Device Sales Closed Vial Access Devices , by Region UNIT (2025-2030)
  • Table 392. Closed System Drug Transfer Device Sales Closed Syringe Safety Devices , by Region UNIT (2025-2030)
  • Table 393. Closed System Drug Transfer Device Sales Closed Bag/Line Access Devices , by Region UNIT (2025-2030)
  • Table 394. Closed System Drug Transfer Device Sales: by Technology Type(UNIT)
  • Table 395. Closed System Drug Transfer Device Sales Diaphragm-based Devices , by Region UNIT (2025-2030)
  • Table 396. Closed System Drug Transfer Device Sales Compartmentalized Devices , by Region UNIT (2025-2030)
  • Table 397. Closed System Drug Transfer Device Sales Air Cleaning/Filtration Devices , by Region UNIT (2025-2030)
  • Table 398. South America Closed System Drug Transfer Device Sales, by Country UNIT (2025-2030)
  • Table 399. South America Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 400. South America Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 401. South America Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 402. South America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 403. Brazil Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 404. Brazil Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 405. Brazil Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 406. Brazil Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 407. Argentina Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 408. Argentina Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 409. Argentina Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 410. Argentina Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 411. Rest of South America Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 412. Rest of South America Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 413. Rest of South America Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 414. Rest of South America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 415. Asia Pacific Closed System Drug Transfer Device Sales, by Country UNIT (2025-2030)
  • Table 416. Asia Pacific Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 417. Asia Pacific Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 418. Asia Pacific Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 419. Asia Pacific Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 420. China Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 421. China Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 422. China Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 423. China Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 424. Japan Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 425. Japan Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 426. Japan Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 427. Japan Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 428. India Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 429. India Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 430. India Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 431. India Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 432. South Korea Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 433. South Korea Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 434. South Korea Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 435. South Korea Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 436. Taiwan Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 437. Taiwan Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 438. Taiwan Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 439. Taiwan Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 440. Australia Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 441. Australia Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 442. Australia Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 443. Australia Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 444. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 445. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 446. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 447. Rest of Asia-Pacific Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 448. Europe Closed System Drug Transfer Device Sales, by Country UNIT (2025-2030)
  • Table 449. Europe Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 450. Europe Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 451. Europe Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 452. Europe Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 453. Germany Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 454. Germany Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 455. Germany Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 456. Germany Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 457. France Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 458. France Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 459. France Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 460. France Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 461. Italy Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 462. Italy Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 463. Italy Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 464. Italy Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 465. United Kingdom Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 466. United Kingdom Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 467. United Kingdom Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 468. United Kingdom Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 469. Netherlands Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 470. Netherlands Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 471. Netherlands Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 472. Netherlands Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 473. Rest of Europe Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 474. Rest of Europe Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 475. Rest of Europe Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 476. Rest of Europe Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 477. MEA Closed System Drug Transfer Device Sales, by Country UNIT (2025-2030)
  • Table 478. MEA Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 479. MEA Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 480. MEA Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 481. MEA Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 482. Middle East Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 483. Middle East Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 484. Middle East Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 485. Middle East Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 486. Africa Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 487. Africa Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 488. Africa Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 489. Africa Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 490. North America Closed System Drug Transfer Device Sales, by Country UNIT (2025-2030)
  • Table 491. North America Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 492. North America Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 493. North America Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 494. North America Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 495. United States Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 496. United States Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 497. United States Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 498. United States Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 499. Canada Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 500. Canada Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 501. Canada Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 502. Canada Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 503. Mexico Closed System Drug Transfer Device Sales, by Type UNIT (2025-2030)
  • Table 504. Mexico Closed System Drug Transfer Device Sales, by Application UNIT (2025-2030)
  • Table 505. Mexico Closed System Drug Transfer Device Sales, by Component Type UNIT (2025-2030)
  • Table 506. Mexico Closed System Drug Transfer Device Sales, by Technology Type UNIT (2025-2030)
  • Table 507. Closed System Drug Transfer Device: by Type(USD/Units)
  • Table 508. Research Programs/Design for This Report
  • Table 509. Key Data Information from Secondary Sources
  • Table 510. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Closed System Drug Transfer Device: by Type USD Million (2018-2023)
  • Figure 5. Global Closed System Drug Transfer Device: by Application USD Million (2018-2023)
  • Figure 6. Global Closed System Drug Transfer Device: by Component Type USD Million (2018-2023)
  • Figure 7. Global Closed System Drug Transfer Device: by Technology Type USD Million (2018-2023)
  • Figure 8. South America Closed System Drug Transfer Device Share (%), by Country
  • Figure 9. Asia Pacific Closed System Drug Transfer Device Share (%), by Country
  • Figure 10. Europe Closed System Drug Transfer Device Share (%), by Country
  • Figure 11. MEA Closed System Drug Transfer Device Share (%), by Country
  • Figure 12. North America Closed System Drug Transfer Device Share (%), by Country
  • Figure 13. Global Closed System Drug Transfer Device: by Type UNIT (2018-2023)
  • Figure 14. Global Closed System Drug Transfer Device: by Application UNIT (2018-2023)
  • Figure 15. Global Closed System Drug Transfer Device: by Component Type UNIT (2018-2023)
  • Figure 16. Global Closed System Drug Transfer Device: by Technology Type UNIT (2018-2023)
  • Figure 17. South America Closed System Drug Transfer Device Share (%), by Country
  • Figure 18. Asia Pacific Closed System Drug Transfer Device Share (%), by Country
  • Figure 19. Europe Closed System Drug Transfer Device Share (%), by Country
  • Figure 20. MEA Closed System Drug Transfer Device Share (%), by Country
  • Figure 21. North America Closed System Drug Transfer Device Share (%), by Country
  • Figure 22. Global Closed System Drug Transfer Device: by Type USD/Units (2018-2023)
  • Figure 23. Global Closed System Drug Transfer Device share by Players 2023 (%)
  • Figure 24. Global Closed System Drug Transfer Device share by Players (Top 3) 2023(%)
  • Figure 25. Global Closed System Drug Transfer Device share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 28. Becton, Dickinson, and Company (United States) Revenue: by Geography 2023
  • Figure 29. ICU Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. ICU Medical, Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Equashield LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Equashield LLC. (United States) Revenue: by Geography 2023
  • Figure 33. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 34. B. Braun Melsungen AG (Germany) Revenue: by Geography 2023
  • Figure 35. Corvida Medical (United States) Revenue, Net Income and Gross profit
  • Figure 36. Corvida Medical (United States) Revenue: by Geography 2023
  • Figure 37. Baxter International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Baxter International, Inc. (United States) Revenue: by Geography 2023
  • Figure 39. VICTUS (United States) Revenue, Net Income and Gross profit
  • Figure 40. VICTUS (United States) Revenue: by Geography 2023
  • Figure 41. Caragen Ltd. (Ireland) Revenue, Net Income and Gross profit
  • Figure 42. Caragen Ltd. (Ireland) Revenue: by Geography 2023
  • Figure 43. Simplivia Healthcare (Israel) Revenue, Net Income and Gross profit
  • Figure 44. Simplivia Healthcare (Israel) Revenue: by Geography 2023
  • Figure 45. Global Closed System Drug Transfer Device: by Type USD Million (2025-2030)
  • Figure 46. Global Closed System Drug Transfer Device: by Application USD Million (2025-2030)
  • Figure 47. Global Closed System Drug Transfer Device: by Component Type USD Million (2025-2030)
  • Figure 48. Global Closed System Drug Transfer Device: by Technology Type USD Million (2025-2030)
  • Figure 49. South America Closed System Drug Transfer Device Share (%), by Country
  • Figure 50. Asia Pacific Closed System Drug Transfer Device Share (%), by Country
  • Figure 51. Europe Closed System Drug Transfer Device Share (%), by Country
  • Figure 52. MEA Closed System Drug Transfer Device Share (%), by Country
  • Figure 53. North America Closed System Drug Transfer Device Share (%), by Country
  • Figure 54. Global Closed System Drug Transfer Device: by Type UNIT (2025-2030)
  • Figure 55. Global Closed System Drug Transfer Device: by Application UNIT (2025-2030)
  • Figure 56. Global Closed System Drug Transfer Device: by Component Type UNIT (2025-2030)
  • Figure 57. Global Closed System Drug Transfer Device: by Technology Type UNIT (2025-2030)
  • Figure 58. South America Closed System Drug Transfer Device Share (%), by Country
  • Figure 59. Asia Pacific Closed System Drug Transfer Device Share (%), by Country
  • Figure 60. Europe Closed System Drug Transfer Device Share (%), by Country
  • Figure 61. MEA Closed System Drug Transfer Device Share (%), by Country
  • Figure 62. North America Closed System Drug Transfer Device Share (%), by Country
  • Figure 63. Global Closed System Drug Transfer Device: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson, and Company (United States)
  • ICU Medical, Inc. (United States)
  • Equashield LLC. (United States)
  • B. Braun Melsungen AG (Germany)
  • Corvida Medical (United States)
  • Baxter International, Inc. (United States)
  • VICTUS (United States)
  • Caragen Ltd. (Ireland)
  • Simplivia Healthcare (Israel)
Additional players considered in the study are as follows:
Yukon Medical (United States) , JMS Co., Ltd. (United States) , CODAN Medizinische Geräte GmbH & Co KG (Germany)
Select User Access Type

Key Highlights of Report


Nov 2024 205 Pages 95 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Closed System Drug Transfer Device Market Quantitative research analysis
Global Closed System Drug Transfer Device Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Closed System Drug Transfer Device Market are by type [Membrane-to-membrane Systems and Needleless Systems], by end use application [Hospitals & Clinics, Oncology Centers and Other End Users].
The Closed System Drug Transfer Device Market is gaining popularity and expected to see strong valuation by 2030.
  • Increasing Number of Oncology Drug Approvals
  • Rising Incidence of Cancer Across the World

Know More About Global Closed System Drug Transfer Device Market Report?

Have a Query? Click Here

Other Related Reports

Disposable Plastic Blood Bag Comprehensive Study by Type (Single Blood Bags, Double Blood Bags, Triple Blood Bags, Quadruple Blood Bags, Others), Application (Blood Banks, Hospitals, Clinics, Others)...
$ 3450
Tongue Depressors Comprehensive Study by Type (Reusable, Disposable), Distribution Channel (Online, Offline), Material Type (Wooden, Metal, Plastic), End-Use (Hospitals, Dental Clinics, Academic & Re...
$ 3350
Hearing Aids Comprehensive Study by Type (In the ear hearing aids (ITE), In the canal (ITC), Completely in the canal (CIC), Behind the ear (BTE), Receiver in canal (RIC)), Distribution Channel (Onlin...
$ 3650
UV Infection Control Device Comprehensive Study by Type (Mobile Type, Stationary Type, Others), Application (Immunodiagnostics, Molecular Diagnostics, Others), End Use (Hospitals, Medical Device Comp...
$ 3450
Body Composition Analyzers Comprehensive Study by Type (Bio-impedance Analyzer, Dual Energy X-ray Absorptiometry Equipment, Skinfold Calipers, Air Displacement Plethysmography Equipment, Hydrostatic ...
$ 3650
Bio-Electronic Comprehensive Study by Type (Bio-Electronic Devices, Bio-Electronic Medicine), Application (Biochips, Implantable Medical Devices, Prosthetic Devices, Artificial Organs/Bionic Organs, ...
$ 3450